Prostate Cancer - Results from #26820

Robotic radical prostatectomy as the initial step in multimodal therapy for men with high-risk localized prostate cancer: Initial experience of 160 men - Abstract November 3, 2011

Screening for prostate cancer: A review of the evidence for the U.S. Preventive Services Task Force - Abstract November 3, 2011

Prostate cancer health and cultural beliefs of black men: The Florida Prostate Cancer Disparity Project - Abstract November 3, 2011

Nodal counts during pelvic lymph node dissection for prostate cancer: An objective indicator of quality under the influence of very subjective factors - Abstract November 3, 2011

Pain in castration-resistant prostate cancer with bone metastases: A qualitative study - Abstract November 3, 2011

Oxidative stress and antioxidant status in prostate cancer patients: Relation to Gleason score, treatment and bone metastasis - Abstract November 3, 2011

Primary intermittent androgen deprivation as initial therapy for men with newly diagnosed prostate cancer - Abstract November 3, 2011

Editor's Commentary - Early continence in patients with localized prostate cancer. A comparison between open retropubic (RRPE) and endoscopic extraperitoneal radical prostatectomy (EERPE) November 3, 2011

Prostate cancer study shows radiation plus hormone therapy greatly improves survival for men with high-risk disease November 3, 2011

Aberrant expression of chromogranin A, miR-146a, and miR-146b-5p in prostate structures with focally disrupted basal cell layers: An early sign of invasion and hormone-refractory cancer? - Abstract November 2, 2011

MicroRNAs associated with metastatic prostate cancer - Abstract November 2, 2011

Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer: A nested case-control study in UK primary care - Abstract November 2, 2011

Biochemical outcome after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy: 12 Years of experience - Abstract November 2, 2011

Characterisation and manipulation of Docetaxel resistant prostate cancer cell lines - Abstract November 2, 2011

The metabolic syndrome and risk of prostate cancer in Italy - Abstract November 2, 2011

Immunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responses - Abstract November 2, 2011

Overall and worst Gleason scores are equally good predictors of prostate cancer progression - Abstract November 1, 2011

Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: A validation study - Abstract November 1, 2011

4D analysis of influence of patient movement and anatomy alteration on the quality of 3D U/S-based prostate HDR brachytherapy treatment delivery - Abstract November 1, 2011

Predictive value of positive surgical margins after radical prostatectomy for lymph node metastasis in locally advanced prostate carcinoma - Abstract November 1, 2011

Page 1342 of 1434